Michael G. Hanna, Jr., Ph.D.
Chairman & CEO
- History & Future
- Vaccinogen Timeline
- Chairman's Letter
- What is OncoVAX®?
- Driving Principles
- Management
- Facilities
- Publications
Dr. Hanna is the founder of Vaccinogen, Inc., the discoverer and developer of OncoVAX®, and a pioneer in the field of cancer vaccines.
He previously served as Chairman (Emeritus) and Chief Scientific Officer of Intracel Resources, an integrated biopharmaceutical company that developed cancer vaccines and immunotherapeutic and diagnostic products for both cancers and infectious diseases.
Dr. Hanna served as President and Chief Executive Officer of PerImmune, Inc. before it and Intracel Corp. merged in 1998. From 1985 to 1994, he was the Chief Operating Officer of Organon Teknika/Biotechnology Research Institute and Senior Vice President of Organon Teknika Corporation, a subsidiary of Akzo Nobel, N.V., The Netherlands. Prior to that, he was Director of the National Cancer Institute, Frederick Cancer Research Center (NCI-FCRC).
Dr. Hanna is the discoverer and developer of OncoVAX®. He also developed and obtained FDA approval for TICE BCG for treatment of Carcinoma in Situ ("CIS") bladder cancer. This led to worldwide registration in 1991. It remains the standard of care for prophylaxis of recurrence of superficial bladder cancer and therapy of CIS.
In addition to cancer therapy research and development, Dr. Hanna has been intellectually involved in Homeland Security. He served as Chairman of the Department of Commerce Biotechnology Advisory Committee (1984-1989), established to prevent potential biological weapons of mass destruction from being obtained by threat countries and organizations. He also served on the Department of Defense Technical Working Group for Biotechnology (1988-1989). PerImmune, the company that Dr. Hanna founded, completed a Department of Defense contract to manufacture the current effective therapeutic for Botulinum toxin. This product is a therapeutic, equine, heptavalent, despeciated immunoglobulin anti-toxin.
Dr. Hanna was Chairman of the Frederick County Local Emergency Planning Committee ("LEPC") responsible for Homeland Security; threat assessment, preparedness and response for a county containing the cross-roads of Baltimore and Washington, D.C., Fort Detrick, FEMA, Camp David, and numerous other sensitive sites.
Dr. Hanna received a doctoral degree in experimental pathology and immunology from the University of Tennessee. He has over 250 publications to his credit, has 10 patents in immunotherapy and has been the recipient of numerous honors, and served on many editorial boards.